Metra CE-marks ultrasound bone device:
This article was originally published in Clinica
Metra Biosystems has CE-marked its QUS-2 quantitative ultrasound device, designed to assess a patient's bone quality by measuring bone at the heel. The self contained, battery-powered device weighs only seven pounds and is intended for use in a doctor's office.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.